|
Market Closed -
Nasdaq
16:00:00 2026-08-12 EDT
|
5-day change | 1st Jan Change | ||
| 4.320 USD | +0.47% |
|
+0.23% | +28.19% |
| 08-06 | Ironwood Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 08-06 | Ironwood Pharmaceuticals, Inc. Raises Earnings Guidance for the Year 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Specialty & Advanced Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 711M | - | - | |||
| 322B | |||||
| 70.24B | |||||
| 11.65B | |||||
| 8.42B | |||||
| 5.02B |
Select your edition
All financial news and data tailored to specific country editions
